Evidence map›Paper›PMID 36499577›Full record

ReviewInternational journal of molecular sciences2022

Plastid Transformation: New Challenges in the Circular Economy Era.

Rachele Tamburino, Loredana Marcolongo, Lorenza Sannino, Elena Ionata, Nunzia Scotti

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Enabling growth-decoupledFrontiers in bioengineering and biotechnology · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rachele TamburinoCNR-IBBR, Institute of Biosciences and BioResources, 80055 Naples, Italy.ORCID 0000-0002-2201-8952
Loredana MarcolongoCNR-IRET, Research Institute on Terrestrial Ecosystems, 80131 Naples, Italy.ORCID 0000-0002-9332-8384
Lorenza SanninoCNR-IBBR, Institute of Biosciences and BioResources, 80055 Naples, Italy.
Elena IonataCNR-IRET, Research Institute on Terrestrial Ecosystems, 80131 Naples, Italy.
Nunzia ScottiCNR-IBBR, Institute of Biosciences and BioResources, 80055 Naples, Italy.ORCID 0000-0002-7792-5955

Funding

Italian Ministry of Research (MiUR) PON03PE_00107_1-BioPoliS
6 · The paper itself

Abstract

In a circular economy era the transition towards renewable and sustainable materials is very urgent. The development of bio-based solutions, that can ensure technological circularity in many priority areas (e.g., agriculture, biotechnology, ecology, green industry, etc.), is very strategic. The agricultural and fishing industry wastes represent important feedstocks that require the development of sustainable and environmentally-friendly industrial processes to produce and recover biofuels, chemicals and bioactive molecules. In this context, the replacement, in industrial processes, of chemicals with enzyme-based catalysts assures great benefits to humans and the environment. In this review, we describe the potentiality of the plastid transformation technology as a sustainable and cheap platform for the production of recombinant industrial enzymes, summarize the current knowledge on the technology, and display examples of cellulolytic enzymes already produced. Further, we illustrate several types of bacterial auxiliary and chitinases/chitin deacetylases enzymes with high biotechnological value that could be manufactured by plastid transformation.

Indexed as

BiofuelsBiotechnologyAgricultureHumansIndustrial WastePlastidsBiofuelsIndustrial Wastechloroplastgenetic transformationindustrial enzymesplant biofactoriesrecombinant proteinstobacco

Identifiers

PMID36499577
PMCPMC9736159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.